Table 2.
LKWu | KO | LKWk | |
---|---|---|---|
24 h follow-up | |||
NIHSS, median (Q1–Q3) | 14 (6–21) | 9 (3–18)a | 12 (5–20)a |
Any intracranial hemorrhage, n (%) | 67 (11.9) | 389 (11.1) | 223 (12.1) |
Symptomatic intracranial hemorrhage, n (%) | 29 (5.2) | 116 (3.3) | 67 (3.6) |
Discharge follow-up | |||
NIHSS, median (Q1–Q3) | 8 (2–16) | 4 (1–12)a | 7 (3–15) |
Length of stay, days, median (Q1–Q3) | 10 (6–15) | 8 (5–13)a | 9 (6–14) |
Death, n (%) | 103 (18.8) | 517 (15.0) | 319 (17.5) |
90 days follow-up | |||
Functional independency (mRS ≤ 2), n (%) | 126 (27.0) | 1297 (42.6) | 514 (31.8) |
mRS, median (Q1–Q3) | 4 (2–6) | 3 (1–6)a | 4 (2–6) |
Death, n (%) | 149 (32.0) | 777 (25.5) | 524 (32.4) |
LKWu time last known well unknown, KO known onset, LWKk time last known well known, NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin scale
aIndicates a significant difference compared to LKWu patients (p < 0.05 in multivariable regression adjusted for age, sex, premorbid mRS, NIHSS at admission, initial Alberta Stroke Programme Early Computed Tomography Score, intravenous thrombolysis, time admission-flow restoration, successful recanalization)